GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (OTCPK:CRLBF) » Definitions » Cyclically Adjusted Price-to-FCF

Cresco Labs (Cresco Labs) Cyclically Adjusted Price-to-FCF : (As of Jun. 07, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cresco Labs Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Cresco Labs's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Cyclically Adjusted Price-to-FCF Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cresco Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cresco Labs's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Cyclically Adjusted Price-to-FCF falls into.



Cresco Labs Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Cresco Labs's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Cresco Labs's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.088/131.7762*131.7762
=0.088

Current CPI (Mar. 2024) = 131.7762.

Cresco Labs Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201404 0.000 100.023 0.000
201407 -0.143 100.520 -0.187
201410 0.000 100.176 0.000
201501 -1.057 98.604 -1.413
201504 0.000 99.824 0.000
201507 0.000 100.691 0.000
201510 0.000 100.346 0.000
201601 2.400 99.957 3.164
201604 0.000 100.947 0.000
201607 0.000 101.524 0.000
201610 0.000 101.988 0.000
201701 -0.657 102.456 -0.845
201704 -2.000 103.167 -2.555
201707 -0.200 103.278 -0.255
201710 0.057 104.070 0.072
201801 3.000 104.578 3.780
201804 0.000 105.708 0.000
201807 0.000 106.324 0.000
201810 -9.875 106.695 -12.196
201903 -0.166 107.251 -0.204
201906 -0.204 108.070 -0.249
201909 -0.265 108.329 -0.322
201912 -0.372 108.420 -0.452
202003 -0.416 108.902 -0.503
202006 -0.118 108.767 -0.143
202009 0.018 109.815 0.022
202012 0.014 109.897 0.017
202103 -0.042 111.754 -0.050
202106 -0.281 114.631 -0.323
202109 -0.071 115.734 -0.081
202112 0.071 117.630 0.080
202203 -0.140 121.301 -0.152
202206 -0.072 125.017 -0.076
202209 0.015 125.227 0.016
202212 -0.032 125.222 -0.034
202303 -0.059 127.348 -0.061
202306 -0.001 128.729 -0.001
202309 0.081 129.860 0.082
202312 -0.025 129.419 -0.025
202403 0.088 131.776 0.088

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cresco Labs  (OTCPK:CRLBF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Cresco Labs Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Cresco Labs's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Cresco Labs (Cresco Labs) Business Description

Traded in Other Exchanges
Address
400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.